Wednesday, February 24, 2021 – Thursday, February 25, 2021, @homeoffice.
First things first: Despite the COVID-19 pandemic, we are – with some exceptions – on track and will have another 4 deliverables ready by the end of February. This is very good news and all this is only possible due to the Consortium being a curious and happy bunch of people. Thank you all for continuing your great work even during those challenging times! We cannot emphasise this point often enough… Thank you, it is always a pleasure to see your smiling faces, even if a meeting in person would of course be best.
We have also, of course, discussed the progress of the project and prepared ourselves for the upcoming mid-term review. It is our pleasure to work with you on all these challenges as the ambition of NeuroDeRisk is to address the challenge of preclinical prediction of neurotoxicity.
